Rafeh Naqash, Assistant Professor at OU Health Stephenson Cancer Center and 2025 Yvonne ‘Mentorship’ Award Winner, shared a post on X:

“Immune Checkpoint Inhibitors for Patients With Autoimmune Neurologic Disorders. Fantastic realworld collaboration on a clinically relevant Q, “

Title: Immune Checkpoint Inhibitors for Patients With Preexisting Autoimmune Neurologic Disorders.

Authors: Kylie Fletcher, Marc Machaalani, Razane El Hajj Chehade, Amin H. Nassar, Rashad Nawfal, Michael Manos, Alexander M. Menzies, Frank Aboubakar-Nana, Jessica C. Hassel, David J. Pinato, Alexandra Johnson, Anna C. Olsson-Brown, Matteo S. Carlino, Andrea Malgeri, Alessio Cortellini, Aditi Singh, Kaushal Parikh, So Yeon Kim, Abdul Rafeh Naqash, Georgina V. Long, Pavan Challa, Toni K. Choueiri, Elad Sharon, Shailee Shah, Douglas B. Johnson

You can read the Full Article on JAMA Network.

Rafeh Naqash Shares Article on Immune Checkpoint Inhibitors For Patients With Autoimmune Neurologic Disorders